56S1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sartorius Stedim Biotech SA

Watchlist Manager

Watchlist

Price: 175.8 EUR -0.11% Market Closed

Market Cap: €17.1B

	Sartorius Stedim Biotech SA F:56S1	FR
B	Brunello Cucinelli SpA F:8BU	IT
S	Schlumberger NV PAR:SLB	US
M	Mid-America Apartment Communities Inc F:M2K	US
I	Intuit Inc DUS:ITU	US
B	Banco Santander SA XMUN:BSD2	ES
	Eiffage SA OTC:EFGSF	FR
A	Airbus SE XBER:AIR	NL
	Japan Tobacco Inc TSE:2914	JP
	Legrand SA PAR:LR	FR
A	Atalaya Mining PLC LSE:ATYM	CY
S	Sumitomo Corp DUS:SUMA	JP
S	Societe Generale SA SWB:SGE	FR
G	General Motors Co XBER:8GM	US
N	Naspers Ltd JSE:NPN	ZA
G	General Motors Co SWB:8GM	US
	Vinci Partners Investments Ltd NASDAQ:VINP	BR
	Alnylam Pharmaceuticals Inc NASDAQ:ALNY	US
	Meggitt PLC LSE:MGGT	UK
F	Flutter Entertainment PLC ISEQ:FLTR	IE
	Benitec Biopharma Inc F:BJ9	US
R	REA Group Ltd F:R9C	AU

Profitability Summary

Sartorius Stedim Biotech SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

45%

Sustainable 3Y Average Gross Margin

45%

Declining Gross Margin

52% > 45%

Healthy Operating Margin

18%

Sustainable 3Y Average Operating Margin

17%

Declining Operating Margin

26% > 18%

Low Net Margin

Low 3Y Average Net Margin

10%

Declining Net Margin

21% > 9%

Exceptional Free Cash Flow Margin

12%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.